Triac Therapy Improves Daily Caregiver Outcomes in Rare MCT8 Deficiency Trial
An exploratory post-hoc analysis of a phase 2 trial reveals that the thyroid hormone analogue Triac significantly improved caregiver-reported outcomes, ...
An exploratory post-hoc analysis of a phase 2 trial reveals that the thyroid hormone analogue Triac significantly improved caregiver-reported outcomes, ...
Single-cell transcriptomics and clinical cohort analyses reveal that orbital fibroblasts express thyroid hormone signaling machinery and release elevated SPARC, establishing ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.